Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10046025 Stabilizing alkylglycoside compositions and methods thereof

Patent 10046025 was granted and assigned to Aegis Therapeutics on August, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Aegis Therapeutics

Current Assignee

Aegis Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Edward T. Maggio0

Date of Patent

August 14, 2018

Patent Application Number

15264393

Date Filed

September 13, 2016

Patent Citations Received

US Patent 11426446 Stable aqueous formulations of aflibercept

0

US Patent 11667702 Stable aqueous formulations of aflibercept

0

Patent Primary Examiner

Jeffrey E. Russel

Patent abstract

The present invention relates to alkylglycoside-containing compositions and methods for increasing the stability, reducing the aggregation and immunogenicity, increasing the biological activity, and reducing or preventing fibrillar formation of a cyclic polypeptide.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10046025 Stabilizing alkylglycoside compositions and methods thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.